Different GLP-1 receptor agonists have varying pharmacokinetic profiles and receptor binding characteristics
Kidney testing should reflect diabetes, hypertension, chronic kidney disease, and dehydration risk
Do not take Wegovy if you have: A personal or family history of medullary thyroid carcinoma (MTC) a specific type of thyroid cancer A condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) A known allergy to semaglutide or any ingredient in Wegovy Talk to your licensed healthcare provider first if you have a history of: Pancreatitis Gallbladder problems Kidney issues Eating disorders Severe gastrointestinal disease Depression or thoughts of self-harm The Wegovy Pen may also not be the right practical fit if: Cost is a significant barrier
The most common side effects reported in clinical trials include nausea, vomiting, diarrhea, and constipation
One in 10 women aged 35-54 are using the drugs, while usage peaks among 25- to 44-year-olds at 13%, says Tamara Sender Ceron, who heads up fashion retail at the market research company Mintel